SG10202006830WA - Treatment of hand eczema - Google Patents

Treatment of hand eczema

Info

Publication number: SG10202006830WA
Authority: SG; Singapore
Prior art keywords: treatment; hand eczema; eczema; hand
Prior art date: 2016-01-21

Application number

SG10202006830WA

Inventor

Tero Wennberg

Anders Per Sørensen

Original Assignee

Leo Pharma As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-01-21

Filing date

2017-01-20

Publication date

2020-08-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55236207&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10202006830W(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-01-20 Application filed by Leo Pharma As filed Critical Leo Pharma As

2020-08-28 Publication of SG10202006830WA publication Critical patent/SG10202006830WA/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Storage Of Fruits Or Vegetables (AREA)

SG10202006830WA 2016-01-21 2017-01-20 Treatment of hand eczema SG10202006830WA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP16152215		2016-01-21

Publications (1)

Publication Number	Publication Date
SG10202006830WA true SG10202006830WA (en)	2020-08-28

Family

ID=55236207

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG10202006830WA SG10202006830WA (en)	2016-01-21	2017-01-20	Treatment of hand eczema
SG11201805394QA SG11201805394QA (en)	2016-01-21	2017-01-20	Treatment of hand eczema

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG11201805394QA SG11201805394QA (en)	2016-01-21	2017-01-20	Treatment of hand eczema

Country Status (31)

Country	Link
US (2)	US20200397787A1 (en)
EP (2)	EP3405197B1 (en)
JP (1)	JP6929860B2 (en)
KR (2)	KR20180102662A (en)
CN (3)	CN117159553A (en)
AU (3)	AU2017209932A1 (en)
BR (1)	BR112018014769A2 (en)
CA (1)	CA3010547A1 (en)
CY (2)	CY1126388T1 (en)
DK (1)	DK3405197T3 (en)
ES (1)	ES2963784T3 (en)
FI (2)	FI3405197T3 (en)
FR (1)	FR24C1053I2 (en)
HR (1)	HRP20231448T1 (en)
HU (2)	HUE064192T2 (en)
IL (4)	IL297379A (en)
LT (2)	LT3405197T (en)
MX (2)	MX394358B (en)
NL (1)	NL301306I2 (en)
NO (1)	NO2024058I1 (en)
PL (1)	PL3405197T3 (en)
PT (1)	PT3405197T (en)
RS (1)	RS64798B1 (en)
RU (1)	RU2018130097A (en)
SG (2)	SG10202006830WA (en)
SI (1)	SI3405197T1 (en)
SM (1)	SMT202300415T1 (en)
TW (2)	TWI841027B (en)
UA (1)	UA123780C2 (en)
WO (1)	WO2017125523A1 (en)
ZA (1)	ZA201804098B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112021022031A2 (en) *	2019-05-15	2021-12-28	Leo Pharma As	Compound, pharmaceutical composition, and pharmaceutical formulation for topical administration
CN116847850A (en) *	2021-02-02	2023-10-03	辉瑞公司	Dosage regimen for treating chronic hand eczema
EP4376844A1 (en) *	2021-07-30	2024-06-05	Eli Lilly and Company	Treatment of hand eczema with baricitinib
AU2024238918A1 (en)	2023-03-17	2025-10-09	Leo Pharma A/S	A method for the treatment of chronic hand eczema in patients with moderate to severe chronic hand eczema

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI466885B (en)	2009-07-31	2015-01-01	Japan Tobacco Inc	Nitrogen-containing spiro compound and its medical use
US20130302298A1 (en) *	2010-11-30	2013-11-14	Bio-K Plus International Inc.	Treatment and prevention of eczema
US20140343034A1 (en) *	2013-04-25	2014-11-20	Japan Tobacco Inc.	Skin barrier function improving agent

2017
- 2017-01-20 AU AU2017209932A patent/AU2017209932A1/en not_active Abandoned
- 2017-01-20 TW TW111141449A patent/TWI841027B/en active
- 2017-01-20 EP EP17701828.0A patent/EP3405197B1/en active Active
- 2017-01-20 UA UAA201808829A patent/UA123780C2/en unknown
- 2017-01-20 CA CA3010547A patent/CA3010547A1/en active Pending
- 2017-01-20 WO PCT/EP2017/051133 patent/WO2017125523A1/en not_active Ceased
- 2017-01-20 ES ES17701828T patent/ES2963784T3/en active Active
- 2017-01-20 IL IL297379A patent/IL297379A/en unknown
- 2017-01-20 SG SG10202006830WA patent/SG10202006830WA/en unknown
- 2017-01-20 PT PT177018280T patent/PT3405197T/en unknown
- 2017-01-20 RU RU2018130097A patent/RU2018130097A/en unknown
- 2017-01-20 IL IL313543A patent/IL313543A/en unknown
- 2017-01-20 KR KR1020187024112A patent/KR20180102662A/en not_active Ceased
- 2017-01-20 JP JP2018538167A patent/JP6929860B2/en active Active
- 2017-01-20 CN CN202311350781.2A patent/CN117159553A/en active Pending
- 2017-01-20 US US16/071,209 patent/US20200397787A1/en not_active Abandoned
- 2017-01-20 IL IL320757A patent/IL320757A/en unknown
- 2017-01-20 CN CN201780006075.2A patent/CN108472297A/en active Pending
- 2017-01-20 SI SI201731440T patent/SI3405197T1/en unknown
- 2017-01-20 DK DK17701828.0T patent/DK3405197T3/en active
- 2017-01-20 SM SM20230415T patent/SMT202300415T1/en unknown
- 2017-01-20 RS RS20231010A patent/RS64798B1/en unknown
- 2017-01-20 FI FIEP17701828.0T patent/FI3405197T3/en active
- 2017-01-20 LT LTEPPCT/EP2017/051133T patent/LT3405197T/en unknown
- 2017-01-20 KR KR1020257019206A patent/KR20250088666A/en active Pending
- 2017-01-20 MX MX2018008449A patent/MX394358B/en unknown
- 2017-01-20 TW TW106102111A patent/TWI783921B/en active
- 2017-01-20 CN CN202311350784.6A patent/CN117159554A/en active Pending
- 2017-01-20 SG SG11201805394QA patent/SG11201805394QA/en unknown
- 2017-01-20 EP EP23195420.7A patent/EP4257205A3/en active Pending
- 2017-01-20 PL PL17701828.0T patent/PL3405197T3/en unknown
- 2017-01-20 HU HUE17701828A patent/HUE064192T2/en unknown
- 2017-01-20 BR BR112018014769-9A patent/BR112018014769A2/en not_active Application Discontinuation
- 2017-01-20 HR HRP20231448TT patent/HRP20231448T1/en unknown
2018
- 2018-06-18 IL IL260094A patent/IL260094A/en unknown
- 2018-06-19 ZA ZA2018/04098A patent/ZA201804098B/en unknown
- 2018-07-09 MX MX2022005915A patent/MX2022005915A/en unknown
2022
- 2022-07-08 US US17/811,347 patent/US20230138114A1/en active Pending
- 2022-10-13 AU AU2022252766A patent/AU2022252766B2/en active Active
2023
- 2023-11-10 CY CY20231100643T patent/CY1126388T1/en unknown
2024
- 2024-11-28 AU AU2024266962A patent/AU2024266962A1/en active Pending
- 2024-12-13 NO NO2024058C patent/NO2024058I1/en unknown
- 2024-12-13 NL NL301306C patent/NL301306I2/en unknown
- 2024-12-15 FR FR24C1053C patent/FR24C1053I2/en active Active
- 2024-12-17 CY CY2024037C patent/CY2024037I2/en unknown
- 2024-12-17 HU HUS2400045C patent/HUS2400045I1/en unknown
- 2024-12-17 LT LTPA2024538C patent/LTPA2024538I1/lt unknown
- 2024-12-19 FI FIC20240048C patent/FIC20240048I1/en unknown

Also Published As

Publication number	Publication date
HUS2400045I1 (en)	2025-01-28
ZA201804098B (en)	2024-10-30
TW201736382A (en)	2017-10-16
CN117159553A (en)	2023-12-05
TWI783921B (en)	2022-11-21
FR24C1053I2 (en)	2025-12-05
ES2963784T3 (en)	2024-04-02
KR20180102662A (en)	2018-09-17
EP3405197B1 (en)	2023-09-06
AU2022252766A1 (en)	2022-11-03
FIC20240048I1 (en)	2024-12-19
TWI841027B (en)	2024-05-01
AU2022252766B2 (en)	2024-08-29
CN108472297A (en)	2018-08-31
AU2024266962A1 (en)	2024-12-19
EP4257205A3 (en)	2023-12-20
CY2024037I1 (en)	2026-02-25
LTPA2024538I1 (en)	2025-01-10
FR24C1053I1 (en)	2025-02-21
NO2024058I1 (en)	2024-12-13
CY1126388T1 (en)	2026-02-25
LT3405197T (en)	2023-11-27
US20200397787A1 (en)	2020-12-24
RU2018130097A (en)	2020-02-21
HUE064192T2 (en)	2024-02-28
SG11201805394QA (en)	2018-08-30
UA123780C2 (en)	2021-06-02
PT3405197T (en)	2023-12-06
JP2019502734A (en)	2019-01-31
AU2017209932A1 (en)	2018-07-05
US20230138114A1 (en)	2023-05-04
IL320757A (en)	2025-07-01
DK3405197T3 (en)	2023-11-27
RS64798B1 (en)	2023-11-30
IL313543A (en)	2024-08-01
IL297379A (en)	2022-12-01
MX2018008449A (en)	2018-08-09
SI3405197T1 (en)	2024-03-29
PL3405197T3 (en)	2024-02-12
EP3405197A1 (en)	2018-11-28
TW202332451A (en)	2023-08-16
JP6929860B2 (en)	2021-09-01
HRP20231448T1 (en)	2024-03-01
SMT202300415T1 (en)	2024-01-10
FI3405197T3 (en)	2023-11-23
BR112018014769A2 (en)	2018-12-11
CA3010547A1 (en)	2017-07-27
RU2018130097A3 (en)	2020-05-25
MX2022005915A (en)	2022-06-27
MX394358B (en)	2025-03-24
NL301306I2 (en)	2024-12-30
WO2017125523A1 (en)	2017-07-27
NZ743582A (en)	2024-12-20
EP4257205A2 (en)	2023-10-11
CY2024037I2 (en)	2026-02-25
IL260094A (en)	2018-07-31
CN117159554A (en)	2023-12-05
KR20250088666A (en)	2025-06-17

Publication	Publication Date	Title
ZA202006746B (en)	2023-03-29	Methods of treatment
HUE041433T2 (en)	2019-05-28	Treatment of fibrosis
IL268694A (en)	2019-10-31	Treatment of schizophrenia
PL3504187T3 (en)	2025-06-09	Use of pridopidine for treating functional decline
SG11201609652RA (en)	2016-12-29	Treatment of polybacterials infections
PT3506904T (en)	2021-02-02	Treatment of dementia
SMT202100245T1 (en)	2021-05-07	Combination treatment of cancer
IL263835A (en)	2019-02-03	Exosome-guided treatment of cancer
HUS2400045I1 (en)	2025-01-28	Use of delgocitinib for the treatment of chronic hand eczema
IL255498A (en)	2018-01-31	Treatment of pruritus
GB201408297D0 (en)	2014-06-25	Treatment of cancer
GB201603546D0 (en)	2016-04-13	Treatment of urine
LT3504163T (en)	2023-11-10	Treatment of wastewater
SG11202005850VA (en)	2020-07-29	Methods of treatment of hypertrigl yceridemia
GB201602802D0 (en)	2016-03-30	Method of treatment
GB201412010D0 (en)	2014-08-20	Treatment of hypertransaminasemia
GB201512139D0 (en)	2015-08-19	Methods of treatment
GB201417456D0 (en)	2014-11-19	Treatment of cancer
GB201622214D0 (en)	2017-02-08	treatment of cancer
GB201604621D0 (en)	2016-05-04	Treatment of cancer
GB201604293D0 (en)	2016-04-27	Treatment of cancer
GB201505633D0 (en)	2015-05-13	Novel treatment of STIs
GB201512723D0 (en)	2015-08-26	Treatment of cancer
GB201608599D0 (en)	2016-06-29	Treatment of opioid tollerence
GB201507928D0 (en)	2015-06-24	Treatment of cancer